CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib, which help slow cancer cell division. Immunotherapy: For some patients with triple-negative breast cancer (which lacks hormone receptors ...

Revenue: Revenue was $0 for the third quarter of 2024, as compared to $25.2 million for the third quarter of 2023. The decrease was primarily due to the recognition of previously received milestone ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

TD Cowen analyst Tyler Van Buren has reiterated their bullish stance on ARVN stock, giving a Buy rating on October 22. Tyler Van Buren’s ...

The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the ...

Basel: This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to ...

This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4/6i) ...

CDK4/CDK6 inhibitors are targeted therapies which attack proteins known as the cyclin-dependent kinases 4 and 6 (CDK4/CDK6). These proteins control how quickly cells divide and multiply, and for women ...

What we didn't expect, though, was that Cobra Kai season 6 wouldn't have one or two launch dates, but three. Indeed, the series is releasing in three volumes: part 1 is out now, part 2 arrives on ...

Call of Duty Black Ops 6 is a spy action thriller set in the early 1990s, a period of transition and upheaval in global politics, characterized by the end of the Cold War and the rise of the ...